The Longevity Divide: Who Gets to Live Forever?

Could 'Poop Pills' Be the Unconventional Secret Weapon Against Cancer?

AstraZeneca's Bold Bet: Charging Hard into China's Obesity Drug Race and Beyond

Absci's AI-Powered Drug Hunt: Unpacking the Potential of ABS-101 and ABS-201

Telangana's Bold Leap: Forging a Global Life Sciences Powerhouse by 2030

The Unsung Heroes of Biotech: How Biological Buffers Are Fueling a $2.39 Billion Revolution

Corvus Pharmaceuticals Takes Key Step Forward with Lead Eczema Drug

Illumina's Crossroads: Navigating the Post-Grail Future in Genomics

Structure Therapeutics CEO Charts Course for Next-Gen Obesity Treatments

Amgen's Horizon: Bradway Shares Strategic Vision with Cramer

More Than Business: Incyte's Identity Forged in the Blood Cancer Battle

Unlocking New Frontiers: How Revolution Medicines and Merck Are Redefining the Cancer Fight

Alnylam's Ambitious Five-Year Vision: Betting Big on Amvuttra and Beyond

The Evolving Landscape of Pharma and Biotech Employment

Cramer's Crystal Ball: Unpacking the Hottest Market Sectors for 2025

Navigating the Future of Wellness: A Human Look at Healthcare's Trajectory Towards 2026

Unlocking Tomorrow's Cures: How Quantum Computing Could Reshape Medicine

The Dawn of AI-Driven Cures: Insilico Medicine's Historic Hong Kong Debut

Regeneron's Remarkable Resurgence: Charting the Course of a Biotech Comeback

Cytokinetics' Myqorzo Secures Landmark FDA Approval, Reshaping HCM Treatment Landscape

A Shifting Landscape: Trump, Cannabis, and the Power of the Purse

The Unseen Revolution: How Mycelium is Forging a Sustainable Future, Billion by Billion

A Game-Changer for Stem Cell Research: Simplifying the Lab and Freezer

Unlocking Life's Secrets: Remote Control Over Proteins in Living Animals

Incyte Unveils Game-Changing Myelofibrosis Data at ASH 2025

ASH 2025: Glimmers of Hope and Big Strides in Blood Disorders

A New Dawn in Cancer Detection: Freenome's Bold Move Towards Public Markets

Vinay Prasad Sounds the Alarm: Media Missteps and Harvard’s Choices Are Hurting Biotech

The Mind Unbound: Max Hodak's Audacious Leap Beyond Neuralink

Stem Cells: A Glimpse into the Future of Medicine

A Revolutionary Leap Towards a Plastic-Free Future

The Anticipation Builds: ASH 2025 and the Evolving Landscape of Blood Cancer Therapies

The FDA's Bold New Vision: Could One Clinical Trial Be Enough for Drug Approval?

A Glimmer of Hope for Hair Loss Sufferers: Cosmo Pharma's Breezula Delivers in Landmark Trial

A Notable Shift: Dr. Theresa Michele Steps Down from FDA's Nonprescription Drug Leadership

A Beacon of Hope: Capricor's Cell Therapy Shows Remarkable Heart Improvements in Duchenne Patients

The Quest for Immortality: Billions Bet on Beating Time Itself

The Enduring Quest: Semaglutide and the Unyielding Challenge of Alzheimer's

A New Horizon: WuXi Biologics Sets Sights on Qatar